GBAP1 functions as a tumor promotor in hepatocellular carcinoma via the PI3K/AKT pathway

Hepatocellular carcinoma (HCC) is common worldwide, and novel therapeutic targets and biomarkers are needed to improve outcomes. In this study, bioinformatics analyses combined with in vitro and in vivo assays were used to identify the potential therapeutic targets. Differentially expressed genes (D...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rong, Zhao, Meng, An, Yanli, Liu, Dongfang, Tang, Qiusha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320987/
https://www.ncbi.nlm.nih.gov/pubmed/37407932
http://dx.doi.org/10.1186/s12885-023-11107-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10320987/
https://www.ncbi.nlm.nih.gov/pubmed/37407932
http://dx.doi.org/10.1186/s12885-023-11107-7

Ejemplares similares